| Primary |
| Type 2 Diabetes Mellitus |
44.1% |
| Diabetes Mellitus |
14.7% |
| Product Used For Unknown Indication |
11.8% |
| Blood Cholesterol Increased |
8.8% |
| Anxiety |
2.9% |
| Asthma |
2.9% |
| Blood Pressure |
2.9% |
| Coagulation Time Abnormal |
2.9% |
| Fluid Retention |
2.9% |
| Gout |
2.9% |
| Hypertension |
2.9% |
|
| International Normalised Ratio Decreased |
14.3% |
| Breast Enlargement |
7.1% |
| Breast Pain |
7.1% |
| Cholelithiasis |
7.1% |
| Hypoglycaemia |
7.1% |
| Malaise |
7.1% |
| Mitral Valve Incompetence |
7.1% |
| Paraesthesia |
7.1% |
| Sleep Disorder |
7.1% |
| Toxic Epidermal Necrolysis |
7.1% |
| Visual Impairment |
7.1% |
| Vomiting |
7.1% |
| Weight Increased |
7.1% |
|
| Secondary |
| Type 2 Diabetes Mellitus |
31.0% |
| Product Used For Unknown Indication |
20.6% |
| Diabetes Mellitus |
12.9% |
| Drug Use For Unknown Indication |
12.7% |
| Hypertension |
6.7% |
| Rheumatoid Arthritis |
1.7% |
| Gout |
1.6% |
| Angina Pectoris |
1.4% |
| Blood Cholesterol Increased |
1.3% |
| Depression |
1.2% |
| Breast Cancer |
1.1% |
| Schizophrenia, Paranoid Type |
1.1% |
| Hyperlipidaemia |
1.0% |
| Anxiety |
0.9% |
| Hypercholesterolaemia |
0.9% |
| Bronchitis |
0.9% |
| Hyperuricaemia |
0.9% |
| Cardiac Failure |
0.8% |
| Diabetic Neuropathy |
0.6% |
| Renal Cell Carcinoma |
0.6% |
|
| Renal Failure Acute |
21.4% |
| Hypoglycaemia |
15.3% |
| Vomiting |
7.9% |
| Pancreatitis |
6.6% |
| Malaise |
4.4% |
| Pancreatic Carcinoma |
4.4% |
| Angioedema |
3.9% |
| Metabolic Acidosis |
3.5% |
| Obesity |
3.5% |
| Renal Impairment |
3.1% |
| Weight Fluctuation |
3.1% |
| Blood Glucose Increased |
2.6% |
| Drug Exposure During Pregnancy |
2.6% |
| Hepatitis |
2.6% |
| Rhabdomyolysis |
2.6% |
| Shock |
2.6% |
| Sleep Terror |
2.6% |
| Weight Decreased |
2.6% |
| Weight Increased |
2.6% |
| Hypoglycaemic Encephalopathy |
2.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
26.4% |
| Drug Use For Unknown Indication |
16.9% |
| Diabetes Mellitus |
14.5% |
| Type 2 Diabetes Mellitus |
10.6% |
| Hypertension |
9.7% |
| Rheumatoid Arthritis |
3.2% |
| Pain |
2.1% |
| Depression |
1.9% |
| Prophylaxis |
1.7% |
| Atrial Fibrillation |
1.7% |
| Blood Cholesterol Increased |
1.7% |
| Schizophrenia |
1.4% |
| Hypercholesterolaemia |
1.4% |
| Angina Pectoris |
1.1% |
| Hyperlipidaemia |
1.1% |
| Asthma |
1.1% |
| Breast Cancer |
1.0% |
| Myocardial Ischaemia |
1.0% |
| Prostate Cancer |
0.9% |
| Dyslipidaemia |
0.8% |
|
| Vomiting |
13.7% |
| Renal Failure Acute |
10.9% |
| Weight Decreased |
8.7% |
| Rhabdomyolysis |
5.1% |
| Renal Failure |
4.8% |
| Pneumonia |
4.7% |
| Hypoglycaemia |
4.5% |
| Weight Increased |
4.3% |
| Death |
4.2% |
| White Blood Cell Count Increased |
4.2% |
| Renal Impairment |
4.0% |
| Sepsis |
4.0% |
| Liver Function Test Abnormal |
3.8% |
| Myocardial Infarction |
3.8% |
| Malaise |
3.6% |
| Syncope |
3.4% |
| Diarrhoea |
3.3% |
| Urinary Tract Infection |
3.3% |
| Psychotic Disorder |
3.2% |
| Myalgia |
3.1% |
|
| Interacting |
| Diabetes Mellitus |
19.4% |
| Drug Use For Unknown Indication |
14.8% |
| Product Used For Unknown Indication |
14.8% |
| Type 2 Diabetes Mellitus |
9.7% |
| Hypertension |
7.1% |
| Upper Respiratory Tract Inflammation |
5.6% |
| Angina Pectoris |
5.1% |
| Anticoagulant Therapy |
3.1% |
| Atypical Mycobacterial Infection |
3.1% |
| Schizophrenia, Paranoid Type |
3.1% |
| Depression |
2.0% |
| Hyperlipidaemia |
2.0% |
| Osteoporosis |
2.0% |
| Upper Respiratory Tract Infection |
2.0% |
| Hypercholesterolaemia |
1.5% |
| Diarrhoea |
1.0% |
| Herpes Zoster |
1.0% |
| Pneumonitis |
1.0% |
| Urosepsis |
1.0% |
| Blood Cholesterol |
0.5% |
|
| Hypoglycaemia |
40.0% |
| Renal Failure Acute |
16.7% |
| Diabetes Mellitus Inadequate Control |
10.0% |
| Renal Tubular Acidosis |
10.0% |
| Coma |
6.7% |
| Weight Decreased |
6.7% |
| International Normalised Ratio Decreased |
3.3% |
| Pain In Extremity |
3.3% |
| Vomiting |
3.3% |
|
